Yakup Iriagac
Balikesir, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
The impact of exercise prehabilitation on upper extremity range of motions, functionality and quality of life in breast cancer survivors: a prospective clinical trial.
Journal: BMC sports science, medicine & rehabilitation
Published: November 04, 2025
Radiotherapy improves outcomes in patients with NSCLC receiving nivolumab.
Journal: BMC cancer
Published: September 23, 2025
Androgen Receptor: Clinical Importance in Breast Cancer Patients Receiving CDK 4/6 Inhibitor Treatment.
Journal: Medicina (Kaunas, Lithuania)
Published: June 27, 2025
The role of peripheral T lymphocyte subsets and PD-1 expression as a biomarker for neoadjuvant treatment response in breast cancer.
Journal: Medicine
Published: June 09, 2025
Expression of gamma-aminobutyric acid type A receptor subunit π and minichromosome maintenance-3 in breast cancer patients treated with neoadjuvant chemotherapy: a target molecule or a proliferation marker?
Journal: Revista da Associacao Medica Brasileira (1992)
Published: April 26, 2025
Predictive Factors for Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Undergoing 177Lu-PSMA-617 Radioligand Treatment.
Journal: Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
Published: February 01, 2025
Melatonin enhances everolimus efficacy in breast cancer by suppressing mTOR pathway activation and promoting apoptosis and mitochondrial function.
Journal: BMC pharmacology & toxicology
Published: December 02, 2024
Nanotechnology in oncology: a mini review.
Journal: Revista da Associacao Medica Brasileira (1992)
Published: September 09, 2024
Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.
Journal: Clinical breast cancer
Published: June 29, 2024
Clinicopathologic Analysis and Prognostic Factors for Survival in Patients with Operable Ampullary Carcinoma: A Multi-Institutional Retrospective Experience.
Journal: Medicina (Kaunas, Lithuania)
Published: May 04, 2024
Correction: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.
Journal: BMC cancer
Published: January 23, 2024
The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey.
Journal: Medicine
Published: November 14, 2023
Last Updated: 09/26/2026